The ten most promising cancer drugs being trialled
Pharmaceutical-technology.com lists some of the most promising cancer drugs that are currently undergoing late-stage clinical trials. Alpelisib, Novartis Alpelisib (BYL719,…
All articles by Rebecca Panks
Rebecca Panks
-
-
Novartis juvenile arthritis drug performs well in trial
Novartis' ACZ885 (canakinumab) has demonstrated positive results in a Phase III trial involving patients with systemic juvenile idiopathic arthritis, a…
-
BARDA funds Vaxin to develop anthrax vaccine
Vaxin, a clinical-stage vaccine development company, has been awarded a $21.7m contract by the Office of Biomedical Advanced Research and…